Teligent, Inc. (TLGT): Price and Financial Metrics


Teligent, Inc. (TLGT): $0.17

-0.03 (-13.85%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add TLGT to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

TLGT Stock Price Chart Interactive Chart >

Price chart for TLGT

TLGT Price/Volume Stats

Current price $0.17 52-week high $1.60
Prev. close $0.20 52-week low $0.17
Day low $0.17 Volume 73,687,200
Day high $0.21 Avg. volume 5,280,363
50-day MA $0.38 Dividend yield N/A
200-day MA $0.63 Market Cap 16.10M

Teligent, Inc. (TLGT) Company Bio


Teligent Inc. is a specialty generic pharmaceutical company developing, manufacturing, and marketing topical formulations in the United States. The company was founded in 1977 and is based in Buena, New Jersey.


TLGT Latest News Stream


Event/Time News Detail
Loading, please wait...

TLGT Latest Social Stream


Loading social stream, please wait...

View Full TLGT Social Stream

Latest TLGT News From Around the Web

Below are the latest news stories about Teligent Inc that investors may wish to consider to help them evaluate TLGT as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Good morning!

William White on InvestorPlace | October 15, 2021

22 Stocks Moving in Friday's Pre-Market Session

Gainers LM Funding America, Inc. (NASDAQ: LMFA) rose 39.5% to $4.80 in pre-market trading after declining around 15% on Thursday. The company recently announced it purchased an additional 4,000 S19J Pro Antminer Machines for a price of $25.3 million to further expand the company's mining capabilities. ABVC BioPharma, Inc. (NASDAQ: ABVC) rose 24.4% to $3.06 in pre-market trading after gaining around 5% on Thursday. ABVC BioPharma recently restructured its joint venture with Lucida. Avadel Pharmac

Yahoo | October 15, 2021

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Good morning, investor!

William White on InvestorPlace | October 14, 2021

Generic drug maker Teligent files for bankruptcy protection, explores sale of the company

South Jersey specialty generic pharmaceutical firm Teligent Inc. filed for voluntarily bankruptcy protection on Thursday as it pursues the sale of the company or its core assets. Teligent Inc. of Buena in Atlantic County also said it is arranging for $12 million debtor-in-possession financing from its senior secured lenders. The company also announced that CEO Tim Sawyer and Philip Yachmetz, Teligent's chief legal officer and executive vice president, resigned effective Oct. 8.

Yahoo | October 14, 2021

Teligent to Pursue Asset Sale through Voluntary Chapter 11 Process

Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company ("Teligent" or the "Company"), today announced that the Company has, together with certain of its affiliates, filed for voluntary protection under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware to pursue a sale process that is intended to maximize the value of the Company.

Yahoo | October 14, 2021

Read More 'TLGT' Stories Here

TLGT Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year -68.97%
3-year -97.30%
5-year -99.81%
YTD N/A
2021 0.00%
2020 -82.39%
2019 -68.91%
2018 -62.26%
2017 -45.08%

Continue Researching TLGT

Want to see what other sources are saying about Teligent Inc's financials and stock price? Try the links below:

Teligent Inc (TLGT) Stock Price | Nasdaq
Teligent Inc (TLGT) Stock Quote, History and News - Yahoo Finance
Teligent Inc (TLGT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.4737 seconds.